Peripheral T-Cell Lymphoma Refractory
3 clinical trials · Condition
◉ Watch Peripheral T-Cell Lymphoma Refractory
| Record | Firm | Date |
|---|---|---|
| Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma (NCT04712864) | Legend Biotech USA Inc | 2021-09-13 |
| Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms (NCT03493451) | BeiGene | 2018-04-13 |
Track Peripheral T-Cell Lymphoma Refractory automatically
Every clearance here is in the API, with alerts when new ones post.